Please use this identifier to cite or link to this item:
|Title:||Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.|
|Author:||Vianna, J. L.|
Haga, H. J.
Cervera i Segura, Ricard, 1960-
Khamashta, Munther A.
Hughes, Graham R. V. (Graham Robert Vivian)
Estudi de casos
|Abstract:||The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphospholipid antibodies in systemic lupus erythematosus (SLE), 95 patients with SLE were studied. Their antiphospholipid antibody profile was analysed and correlated with clinical findings such as thrombosis, abortions, or thrombocytopenia. A low prevalence of these antibodies was found (13 patients; 14%) with a high specificity for thrombosis (92%) and abortions (92%). The importance of anticardiolipin antibodies as a risk factor for thrombosis or abortions, or both, in patients with SLE is reaffirmed by this work.|
|Note:||Reproducció digital del document publicat a: http://dx.doi.org/10.1136/ard.51.2.160|
|It is part of:||Annals of the Rheumatic Diseases, 1992, vol. 51, núm. 2, p. 160-161|
|Appears in Collections:||Articles publicats en revistes (Medicina)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.